Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study

Fig. 1

Cholesterol efflux capacity in patients with CHD. A) According to the presence or absence of PAD and B) According to the presence or absence of PAD and diabetes status * Significant differences between PAD and no PAD in each diabetes status s group. Different common letter superscripts denote significant differences among non-T2DM, newly-diagnosed T2DM and established T2DM. p1, effect of presence or absence of PAD; p2, effect of diabetes status; p3, interaction between presence of absence of PAD and diabetes status. CHD, coronary heart disease; PAD, peripheral artery disease; T2DM, type 2 diabetes mellitus Analyses were adjusted age, smoking habit, hypertension, eGFR, and medications—glucose-lowering treatment, lipid-lowering therapy, and anti-hypertensive drugs

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840